
Cleveland Cavaliers · — · #—
—
| Period | GP | MIN | PTS | REB | AST | PRA | STL | BLK | TOV | 2PM | 2PA | 2P% | 3PM | 3PA | 3P% | FTM | FTA | FT% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Last 3 | 3 | 25.9 | 15.0 | 10.0 | 0.3 | 25.3 | 1.3 | 0.7 | 1.7 | 4.7 | 8.7 |
| 53.8% |
| 0.0 |
| 0.0 |
| 0.0% |
| 5.7 |
| 9.3 |
| 60.7% |
| Last 5 | 5 | 22.9 | 16.2 | 8.8 | 0.6 | 25.6 | 1.0 | 0.6 | 1.2 | 6.2 | 9.4 | 66.0% | 0.0 | 0.0 | 0.0% | 3.8 | 6.4 | 59.4% |
| Last 10 | 10 | 26.0 | 18.0 | 8.3 | 1.0 | 27.3 | 1.1 | 0.7 | 1.2 | 6.9 | 10.1 | 68.3% | 0.0 | 0.0 | 0.0% | 4.2 | 6.5 | 64.6% |
| Last 20 | 20 | 26.9 | 19.1 | 9.8 | 1.6 | 30.5 | 0.9 | 0.9 | 1.1 | 7.7 | 10.8 | 71.2% | 0.0 | 0.1 | 0.0% | 3.9 | 6.0 | 64.2% |
| Season | 56 | 27.1 | 15.4 | 8.5 | 1.8 | 25.6 | 1.0 | 0.8 | 1.3 | 6.0 | 9.2 | 64.9% | 0.0 | 0.2 | 10.0% | 3.3 | 4.7 | 70.9% |
high post-ups, high contested shots per minute, high rim finishing off the ball, high offensive rebounding
2025-26 season · fitted over 2022-23–2025-26
Style profile over 446 qualified players (8+ games, 10+ min/game). 100% is an identical profile; 50% is unrelated.
| Date | Matchup | W/L | MIN | PTS | REB | AST | STL | BLK | TOV | FGM | FGA | FG% | 3PM | 3PA | 3P% | FTM | FTA | FT% | +/- |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-08 | CLE vs. ATL | W | 29.1 | 16 | 8 | 0 | 2 | 0 | 3 | 4 | 9 | 44.4% | 0 | 0 | 0.0% | 8 | 11 | 72.7% | 3.0 |
| 2026-04-06 | CLE @ MEM | W | 24.8 | 13 | 9 | 1 | 1 | 2 | 2 | 5 | 7 | 71.4% | 0 | 0 | 0.0% | 3 | 5 | 60.0% | 11.0 |
| 2026-04-02 | CLE @ GSW | W | 23.9 | 16 | 13 | 0 | 1 | 0 | 0 | 5 | 10 | 50.0% | 0 | 0 | 0.0% | 6 | 12 | 50.0% | 12.0 |
| 2026-03-31 | CLE @ LAL | L | 18.6 | 18 | 4 | 2 | 1 | 0 | 1 | 9 | 11 | 81.8% | 0 | 0 | 0.0% | 0 | 2 | 0.0% | -7.0 |
| 2026-03-27 | CLE vs. MIA | W | 18.3 | 18 | 10 | 0 | 0 | 1 | 0 | 8 | 10 | 80.0% | 0 | 0 | 0.0% | 2 | 2 | 100.0% | 18.0 |
| 2026-03-03 | CLE vs. DET | W | 20.5 | 8 | 3 | 0 | 1 | 0 | 1 | 4 | 7 | 57.1% | 0 | 0 | 0.0% | 0 | 2 | 0.0% | -3.0 |
| 2026-03-01 | CLE @ BKN | W | 31.8 | 20 | 6 | 1 | 2 | 0 | 2 | 7 | 12 | 58.3% | 0 | 0 | 0.0% | 6 | 8 | 75.0% | 5.0 |
| 2026-02-27 | CLE @ DET | L | 31.5 | 25 | 9 | 4 | 0 | 1 | 1 | 10 | 12 | 83.3% | 0 | 0 | 0.0% | 5 | 8 | 62.5% | -9.0 |
| 2026-02-25 | CLE @ MIL | L | 32.3 | 27 | 11 | 1 | 2 | 1 | 1 | 10 | 15 | 66.7% | 0 | 0 | 0.0% | 7 | 8 | 87.5% | -10.0 |
| 2026-02-24 | CLE vs. NYK | W | 28.8 | 19 | 10 | 1 | 1 | 2 | 1 | 7 | 8 | 87.5% | 0 | 0 | 0.0% | 5 | 7 | 71.4% | 11.0 |
| 2026-02-22 | CLE @ OKC | L | 28.6 | 11 | 13 | 2 | 1 | 0 | 3 | 4 | 6 | 66.7% | 0 | 0 | 0.0% | 3 | 6 | 50.0% | -15.0 |
| 2026-02-20 | CLE @ CHA | W | 32.1 | 26 | 14 | 2 | 0 | 1 | 1 | 11 | 15 | 73.3% | 0 | 0 | 0.0% | 4 | 5 | 80.0% | -2.0 |
| 2026-02-19 | CLE vs. BKN | W | 23.8 | 15 | 10 | 1 | 1 | 2 | 0 | 5 | 8 | 62.5% | 0 | 1 | 0.0% | 5 | 10 | 50.0% | 31.0 |
| 2026-02-11 | CLE vs. WAS | W | 26.6 | 21 | 9 | 1 | 0 | 2 | 2 | 8 | 8 | 100.0% | 0 | 0 | 0.0% | 5 | 6 | 83.3% | 25.0 |
| 2026-02-09 | CLE @ DEN | W | 34.6 | 22 | 13 | 1 | 0 | 0 | 0 | 10 | 16 | 62.5% | 0 | 0 | 0.0% | 2 | 4 | 50.0% | 8.0 |
| 2026-02-07 | CLE @ SAC | W | 32.7 | 29 | 10 | 1 | 0 | 0 | 1 | 11 | 12 | 91.7% | 0 | 0 | 0.0% | 7 | 8 | 87.5% | -18.0 |
| 2026-02-04 | CLE @ LAC | W | 23.4 | 10 | 11 | 3 | 2 | 1 | 0 | 5 | 8 | 62.5% | 0 | 0 | 0.0% | 0 | 2 | 0.0% | 20.0 |
| 2026-02-01 | CLE @ POR | W | 29.5 | 40 | 17 | 5 | 2 | 4 | 0 | 16 | 23 | 69.6% | 0 | 1 | 0.0% | 8 | 12 | 66.7% | 25.0 |
| 2026-01-30 | CLE @ PHX | L | 23.1 | 12 | 7 | 3 | 1 | 1 | 1 | 6 | 9 | 66.7% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -27.0 |
| 2026-01-28 | CLE vs. LAL | W | 24.1 | 17 | 9 | 2 | 1 | 0 | 2 | 8 | 11 | 72.7% | 0 | 0 | 0.0% | 1 | 2 | 50.0% | 24.0 |
| 2026-01-26 | CLE vs. ORL | W | 33.2 | 9 | 4 | 1 | 0 | 0 | 0 | 4 | 6 | 66.7% | 0 | 0 | 0.0% | 1 | 3 | 33.3% | 18.0 |
| 2026-01-24 | CLE @ ORL | W | 24.8 | 8 | 6 | 1 | 3 | 2 | 2 | 3 | 5 | 60.0% | 0 | 1 | 0.0% | 2 | 2 | 100.0% | 7.0 |
| 2026-01-23 | CLE vs. SAC | W | 33.6 | 15 | 9 | 0 | 2 | 1 | 0 | 3 | 6 | 50.0% | 0 | 0 | 0.0% | 9 | 10 | 90.0% | 7.0 |
| 2026-01-21 | CLE @ CHA | W | 34.6 | 13 | 9 | 0 | 0 | 2 | 1 | 4 | 8 | 50.0% | 0 | 0 | 0.0% | 5 | 6 | 83.3% | -3.0 |
| 2026-01-19 | CLE vs. OKC | L | 28.6 | 16 | 9 | 1 | 0 | 3 | 1 | 4 | 8 | 50.0% | 0 | 0 | 0.0% | 8 | 10 | 80.0% | -31.0 |
| 2026-01-16 | CLE @ PHI | W | 33.2 | 10 | 7 | 1 | 1 | 0 | 2 | 4 | 6 | 66.7% | 0 | 0 | 0.0% | 2 | 2 | 100.0% | 5.0 |
| 2026-01-14 | CLE @ PHI | W | 25.6 | 10 | 5 | 2 | 0 | 0 | 2 | 5 | 6 | 83.3% | 0 | 0 | 0.0% | 0 | 1 | 0.0% | 16.0 |
| 2026-01-12 | CLE vs. UTA | L | 32.4 | 8 | 4 | 3 | 1 | 0 | 2 | 3 | 7 | 42.9% | 0 | 0 | 0.0% | 2 | 2 | 100.0% | -6.0 |
| 2026-01-10 | CLE vs. MIN | W | 28.2 | 16 | 11 | 4 | 1 | 1 | 0 | 6 | 10 | 60.0% | 0 | 0 | 0.0% | 4 | 5 | 80.0% | 22.0 |
| 2026-01-08 | CLE @ MIN | L | 29.9 | 11 | 10 | 1 | 2 | 0 | 0 | 5 | 9 | 55.6% | 0 | 0 | 0.0% | 1 | 2 | 50.0% | -29.0 |
| 2026-01-06 | CLE @ IND | W | 33.7 | 19 | 12 | 4 | 2 | 0 | 2 | 8 | 13 | 61.5% | 0 | 1 | 0.0% | 3 | 6 | 50.0% | 3.0 |
| 2026-01-02 | CLE vs. DEN | W | 29.8 | 8 | 12 | 3 | 1 | 1 | 2 | 3 | 5 | 60.0% | 0 | 0 | 0.0% | 2 | 2 | 100.0% | 12.0 |
| 2025-12-31 | CLE vs. PHX | W | 26.6 | 16 | 11 | 3 | 0 | 0 | 2 | 7 | 12 | 58.3% | 0 | 0 | 0.0% | 2 | 2 | 100.0% | 18.0 |
| 2025-12-29 | CLE @ SAS | W | 28.1 | 27 | 10 | 0 | 2 | 0 | 2 | 11 | 21 | 52.4% | 0 | 1 | 0.0% | 5 | 7 | 71.4% | 9.0 |
| 2025-12-27 | CLE @ HOU | L | 17.6 | 6 | 4 | 2 | 2 | 1 | 2 | 3 | 3 | 100.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -5.0 |
| 2025-12-25 | CLE @ NYK | L | 23.1 | 7 | 8 | 2 | 0 | 0 | 2 | 3 | 4 | 75.0% | 0 | 0 | 0.0% | 1 | 2 | 50.0% | -3.0 |
| 2025-12-23 | CLE vs. NOP | W | 26.3 | 14 | 9 | 3 | 0 | 0 | 1 | 6 | 9 | 66.7% | 1 | 1 | 100.0% | 1 | 2 | 50.0% | 15.0 |
| 2025-12-22 | CLE vs. CHA | W | 19.8 | 12 | 5 | 2 | 1 | 2 | 2 | 4 | 4 | 100.0% | 0 | 0 | 0.0% | 4 | 4 | 100.0% | 4.0 |
| 2025-12-19 | CLE vs. CHI | L | 29.8 | 14 | 12 | 5 | 2 | 1 | 1 | 6 | 9 | 66.7% | 0 | 0 | 0.0% | 2 | 2 | 100.0% | -8.0 |
| 2025-12-17 | CLE @ CHI | L | 27.6 | 14 | 6 | 3 | 1 | 2 | 2 | 7 | 9 | 77.8% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -13.0 |
| 2025-12-14 | CLE vs. CHA | L | 22.9 | 9 | 3 | 1 | 0 | 0 | 1 | 3 | 8 | 37.5% | 0 | 0 | 0.0% | 3 | 5 | 60.0% | -5.0 |
| 2025-11-28 | CLE @ ATL | L | 28.0 | 8 | 8 | 1 | 0 | 1 | 2 | 3 | 6 | 50.0% | 0 | 0 | 0.0% | 2 | 2 | 100.0% | -18.0 |
| 2025-11-19 | CLE vs. HOU | L | 28.3 | 8 | 7 | 3 | 1 | 0 | 1 | 4 | 9 | 44.4% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -9.0 |
| 2025-11-17 | CLE vs. MIL | W | 24.8 | 12 | 6 | 2 | 0 | 1 | 2 | 4 | 7 | 57.1% | 0 | 0 | 0.0% | 4 | 4 | 100.0% | 0.0 |
| 2025-11-15 | CLE vs. MEM | W | 26.4 | 16 | 6 | 2 | 0 | 1 | 2 | 5 | 8 | 62.5% | 0 | 0 | 0.0% | 6 | 8 | 75.0% | 1.0 |
| 2025-11-13 | CLE vs. TOR | L | 20.9 | 6 | 8 | 0 | 1 | 1 | 2 | 3 | 6 | 50.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -6.0 |
| 2025-11-12 | CLE @ MIA | W | 27.4 | 30 | 10 | 2 | 0 | 0 | 1 | 12 | 20 | 60.0% | 0 | 1 | 0.0% | 6 | 7 | 85.7% | 2.0 |
| 2025-11-10 | CLE @ MIA | L | 20.9 | 14 | 7 | 2 | 0 | 1 | 3 | 6 | 9 | 66.7% | 0 | 0 | 0.0% | 2 | 3 | 66.7% | 8.0 |
| 2025-11-08 | CLE vs. CHI | W | 24.6 | 11 | 3 | 2 | 1 | 2 | 2 | 4 | 8 | 50.0% | 0 | 0 | 0.0% | 3 | 6 | 50.0% | 3.0 |
| 2025-11-07 | CLE @ WAS | W | 26.0 | 16 | 14 | 3 | 2 | 1 | 1 | 7 | 13 | 53.8% | 0 | 0 | 0.0% | 2 | 4 | 50.0% | 27.0 |
| 2025-11-05 | CLE vs. PHI | W | 29.5 | 24 | 10 | 1 | 3 | 3 | 0 | 11 | 17 | 64.7% | 0 | 2 | 0.0% | 2 | 2 | 100.0% | 24.0 |
| 2025-10-29 | CLE @ BOS | L | 25.0 | 16 | 6 | 1 | 1 | 1 | 1 | 4 | 7 | 57.1% | 0 | 0 | 0.0% | 8 | 8 | 100.0% | -4.0 |
| 2025-10-27 | CLE @ DET | W | 25.2 | 20 | 7 | 2 | 1 | 0 | 3 | 7 | 12 | 58.3% | 0 | 0 | 0.0% | 6 | 7 | 85.7% | 18.0 |
| 2025-10-26 | CLE vs. MIL | W | 26.2 | 8 | 11 | 1 | 1 | 0 | 1 | 3 | 6 | 50.0% | 0 | 0 | 0.0% | 2 | 2 | 100.0% | 12.0 |
| 2025-10-24 | CLE @ BKN | W | 30.4 | 22 | 7 | 4 | 2 | 1 | 2 | 8 | 11 | 72.7% | 0 | 1 | 0.0% | 6 | 9 | 66.7% | 24.0 |
| 2025-10-22 | CLE @ NYK | L | 28.2 | 4 | 4 | 1 | 2 | 0 | 1 | 1 | 4 | 25.0% | 0 | 0 | 0.0% | 2 | 4 | 50.0% | -4.0 |